← Back to Search

Genotype Feedback Intervention for Healthy Subjects (R21AA28365 Trial)

N/A
Waitlist Available
Led By Susan E. Luczak, Ph.D.
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline through 10-months post-intervention
Awards & highlights

R21AA28365 Trial Summary

This trial looks at how well personalized information about the risks associated with alcohol metabolism variants ALDH2*2 allele affects early drinking behavior.

R21AA28365 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline through 10-months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline through 10-months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Alcohol peak consumption
Secondary outcome measures
Alcohol consumption
Alcohol frequency of consumption
Alcohol weekend consumption
+2 more

R21AA28365 Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Phenotype and Genotype Feedback (PHEN+GENE)Experimental Treatment2 Interventions
Participants receive the PHEN and GENE interventions.
Group II: Phenotype Feedback (PHEN)Experimental Treatment1 Intervention
Participants receive the PHEN intervention.
Group III: Control (CONTROL)Active Control1 Intervention
Participants do not receive PHEN or GENE.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Phenotype Feedback Intervention
2021
N/A
~360
Genotype Feedback Intervention
2021
N/A
~360

Find a Location

Who is running the clinical trial?

University of Southern CaliforniaLead Sponsor
906 Previous Clinical Trials
1,595,928 Total Patients Enrolled
Susan E. Luczak, Ph.D.Principal InvestigatorUniversity of Southern California

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research endeavor accept individuals aged 55 and up?

"This trial is accepting participants aged between 17 and 25 years old."

Answered by AI

Are there any particular demographics that are more conducive to participating in this research?

"Prospective participants for this research must be between 17 and 25 years old, with no known medical conditions. Approximately 360 individuals are required to complete the trial."

Answered by AI

Is recruitment still underway for this research endeavor?

"According to the clinicaltrials.gov website, this trial has ceased recruitment activities since its last update on April 14th 2022. There are 839 other trials actively seeking participants at the present moment in time."

Answered by AI

Who else is applying?

What state do they live in?
California
How old are they?
18 - 65
What site did they apply to?
University of Southern California
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Alcohol Metabolism and Disease Risk in Asians
Susan Luczak 2021. "Alcohol Metabolism and Disease Risk in Asians". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04967599.
~98 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top